Sigilon Therapeutics, Inc.
Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with m…
Biotechnology
US, Cambridge [HQ]
Value per Employee (VpE) · Surveys · Talents
Employees Analysis
Value per Employee (VpE) · Surveys · Talents
Employee Surveys
Employees Asked: -No survey available at the moment.